Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Friedreich's ataxia.

Gulay Alper1, Vinodh Narayanan

  • 1Division of Child Neurology, Department of Pediatrics, Children's Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15213, USA.

Pediatric Neurology
|July 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISGylation is disrupted by <i>UBA7</i> gene variants identified in individuals with neurodevelopmental disorder phenotypes.

iScience·2026
Same author

Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson-Forssman-Lehmann (BFLS) and White-Kernohan (WHIKERS) Syndromes.

Genes·2025
Same author

Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum.

American journal of human genetics·2025
Same author

De novo variants in RYBP are associated with a severe neurodevelopmental disorder and congenital anomalies.

Genetics in medicine : official journal of the American College of Medical Genetics·2025
Same author

Duchenne Muscular Dystrophy in Two Half-Brothers Due to Inherited 306 Kb Inverted Insertion of 10p15.1 into Intron 44 of the Dp427m Transcript of the <i>DMD</i> Gene.

International journal of molecular sciences·2024
Same author

Recurrent p.H119Y variant in MAP2K1 expands the phenotypic spectrum of MAP2K1 -related RASopathy.

American journal of medical genetics. Part A·2024

Friedreich's ataxia, a common hereditary ataxia, stems from a GAA triplet expansion in the frataxin gene. This genetic defect impairs mitochondrial function, leading to disease progression and offering therapeutic targets.

Area of Science:

  • Genetics
  • Neuroscience
  • Mitochondrial Biology

Background:

  • Friedreich's ataxia is the most prevalent hereditary ataxia.
  • It is characterized by a GAA triplet expansion in the frataxin gene (FXN) on chromosome 9q13.
  • The expanded repeat size correlates with disease severity.

Purpose of the Study:

  • To review the significant advancements in understanding Friedreich's ataxia.
  • To cover gene identification, pathogenesis, and therapeutic strategies.
  • To highlight progress in nuclear-encoded mitochondrial disease research.

Main Methods:

  • Gene mapping and identification.
  • Analysis of frataxin protein function in iron homeostasis.
  • Investigation of mitochondrial dysfunction and oxidative stress pathways.

Related Experiment Videos

  • Review of current and emerging therapeutic approaches.

    • Main Results:

    • Identification of the causative gene and its specific mutation (GAA expansion).
    • Elucidation of frataxin's role in mitochondrial iron regulation.
    • Understanding of the link between frataxin deficiency, oxidative stress, and cell death.
    • Correlation established between repeat length and clinical phenotype severity.

    Conclusions:

    • Friedreich's ataxia is a genetically defined mitochondrial disorder.
    • Understanding frataxin's role is key to disease mechanisms.
    • Recent progress offers promising therapeutic avenues for this hereditary ataxia.